How we approach an acquired thrombotic thrombocytopenic purpura patient

Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP

(2014) S. R. Cataland et al.   BLOOD

Cardiac Injury Is a Common Postmortem Finding in Thrombotic Thrombocytopenic Purpura Patients: Is Empiric Cardiac Monitoring and Protection Needed?

(2014) Larry Nichols et al.   THERAPEUTIC APHERESIS AND DIALYSIS

Use of eculizumab in the treatment of a case of refractory, ADAMTS13-deficient thrombotic thrombocytopenic purpura: additional data and clinical follow-up

(2013) Eugenia Tsai et al.   BRITISH JOURNAL OF HAEMATOLOGY

Bortezomib induces clinical remission and reduction of ADAMTS13 inhibitory antibodies in relapsed refractory idiopathic thrombotic thrombocytopenic purpura

(2013) Marshall A. Mazepa et al.   BRITISH JOURNAL OF HAEMATOLOGY

The use of 50% albumin/plasma replacement fluid in therapeutic plasma exchange for thrombotic thrombocytopenic purpura

(2013) Kerry L. O'Brien et al.   JOURNAL OF CLINICAL APHERESIS

Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research

(2013) Ravi Sarode et al.   JOURNAL OF CLINICAL APHERESIS

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue

(2013) Joseph Schwartz et al.   JOURNAL OF CLINICAL APHERESIS

ADAMTS13 Antibody Depletion by Bortezomib in Thrombotic Thrombocytopenic Purpura

(2013) Jake Shortt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura

(2012) John Chapin et al.   BRITISH JOURNAL OF HAEMATOLOGY

Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies

(2012) Marie Scully et al.   BRITISH JOURNAL OF HAEMATOLOGY

Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience

(2012) Y. Benhamou et al.   HAEMATOLOGICA

Splenectomy and/or cyclophosphamide as salvage therapies in thrombotic thrombocytopenic purpura: the French TMA Reference Center experience

(2012) François Beloncle et al.   TRANSFUSION

Systemic infections mimicking thrombotic thrombocytopenic purpura

(2011) Kristina K. Booth et al.   AMERICAN JOURNAL OF HEMATOLOGY

A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura

(2011) M. Scully et al.   BLOOD

ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes

(2011) G. ZINI et al.   International Journal of Laboratory Hematology

Thrombotic Thrombocytopenic Purpura and Urinary Tract Infections

(2010) Yara A. Park et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Theoretical efficacy of using albumin/plasma versus full plasma replacement in TTP

(2010) Mark E. Brecher et al.   JOURNAL OF CLINICAL APHERESIS

Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocytopenic purpura

(2010) V. MCDONALD et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience

(2010) Paul Coppo et al.   PLoS One

Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab

(2010) Domenica Caramazza et al.   TRANSFUSION

Survival and relapse in patients with thrombotic thrombocytopenic purpura

(2009) J. A. K. Hovinga et al.   BLOOD

Proteasome inhibition for antibody-mediated rejection

(2009) Jason J Everly et al.   Current Opinion in Organ Transplantation

Is it quinine TTP/HUS or quinine TMA? ADAMTS13 levels and implications for therapy

(2009) Yara A. Park et al.   JOURNAL OF CLINICAL APHERESIS

Cardiac involvement in acute thrombotic thrombocytopenic purpura: association with troponin T and IgG antibodies to ADAMTS 13

(2009) C. HUGHES et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Thrombotic thrombocytopenic purpura at the Johns Hopkins Hospital from 1992 to 2008: clinical outcomes and risk factors for relapse

(2009) Huichun Zhan et al.   TRANSFUSION

Abrogation of Anti-HLA Antibodies via Proteasome Inhibition

(2009) Hargovind L. Trivedi et al.   TRANSPLANTATION

Proteasome Inhibition Reduces Donor-Specific Antibody Levels

(2009) M.J. Everly et al.   TRANSPLANTATION PROCEEDINGS

Is it HIV TTP or HIV-associated thrombotic microangiopathy?

(2008) Mark E. Brecher et al.   JOURNAL OF CLINICAL APHERESIS